Skip to main content

July 2018 - Philipp Wohlfarth

Dr. Philipp Wohlfarth

MedUni Wien RESEARCHER OF THE MONTH July 2018

Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

Selected Literature

1.    Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D et al: Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant 2016, 51(6):786-792.
2.    Yadav H, Nolan ME, Bohman JK, Cartin-Ceba R, Peters SG, Hogan WJ, Gajic O, Kor DJ: Epidemiology of Acute Respiratory Distress Syndrome Following Hematopoietic Stem Cell Transplantation. Crit Care Med 2016.
3.    Azoulay E, Lemiale V, Mokart D, Pene F, Kouatchet A, Perez P, Vincent F, Mayaux J, Benoit D, Bruneel F et al: Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 2014, 40(8):1106-1114.
4.    Schmidt M, Brechot N, Combes A: Ten situations in which ECMO is unlikely to be successful. Intensive Care Med 2015.
5.    Staudacher DL, Bode C, Wengenmayer T: Four situations in which ECMO might have a chance. Intensive Care Med 2016, 42(8):1305-1306.
6.    Park PK: Extracorporeal Membrane Oxygenation Support Following Stem Cell Transplant-When Is All That We Have Still Not Enough? Crit Care Med 2017, 45(5):925-926.
7.    Wohlfarth P, Beutel G, Lebiedz P, Stemmler HJ, Staudinger T, Schmidt M, Kochanek M, Liebregts T, Taccone FS, Azoulay E et al: Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. Crit Care Med 2017, 45(5):e500-e507.
8.    Wohlfarth P, Ullrich R, Staudinger T, Bojic A, Robak O, Hermann A, Lubsczyk B, Worel N, Fuhrmann V, Schoder M et al: Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care 2014, 18(1):R20.
9.    Wohlfarth P, Agis H, Gualdoni GA, Weber J, Staudinger T, Schellongowski P, Robak O: Interleukin-1 receptor antagonist anakinra, intravenous immunoglobulin and corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis. Journal of Intensive Care Medicne 2017(In Press).
10.    Wohlfarth P, Carlstrom A, Staudinger T, Clauss S, Hermann A, Rabitsch W, Bojic A, Skrabs C, Porpaczy E, Schiefer AI et al: Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma. Leuk Lymphoma 2016, 57(8):1831-1838.
11.    Wohlfarth P, Staudinger T, Sperr WR, Bojic A, Robak O, Hermann A, Laczika K, Carlstrom A, Riss K, Rabitsch W et al: Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Annals of hematology 2014, 93(10):1629-1636.
12.    Wohlfarth P, Turki A, Steinmann J, Fiedler M, Steckel NK, Beelen DW, Liebregts T: Microbiological diagnostic work-up of acute respiratory failure with pulmonary infiltrates following allogeneic hematopoietic stem cell transplantation: findings in the era of molecular and biomarker-based assays. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018, In Press.


Dr. Philipp Wohlfarth

Einrichtung für Knochenmark- und Stammzelltransplantation
Universitätsklinik für Innere Medizin I
Medizinische Universität Wien
A-1090 Wien, Währinger Gürtel 18-20

Tel.: +43 (0)1 40400-57050
Email: philipp.wohlfarth@meduniwien.ac.at